Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$8.35 - $33.63
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $1.03B |
EV | $1.83B |
Shares Outstanding | 115.05M |
Beta | 1.20 |
Analyst Rating | BUY |
Analyst Target Price | $15.15 |
P/E 2025E | 18.93x |
P/Revenue 2025E | 0.50x |
Revenue | 41.20% |
EPS | 173.70% |
Operating Cash Flow | -21.50% |
Free Cash Flow | - |
Revenue | 2.80% |
EPS | 38.10% |
Operating Cash Flow | 109.70% |
Free Cash Flow | - |
Gross Margin 2025E | 16.49% |
Net Profit Margin 2025E | -3.96% |
ROE 2025E | 5.98% |
ROCE 2024 | -9.03% |
DPS 2025E | $0.26 |
Payout Ratio 2025E | 55.32% |
Div. Yield 2025E | 2.87% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Evolent Health, Inc.
EVH
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Blackley, Seth
Employees
4,500
Website
www.evolent.comIPO Date
2015-06-05
Headquarters
1812 N. Moore Street, Suite 1705, Arlington, Virginia, 22209, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved